Skip to content
DataLookout
Menu

NCT05266144

Atrial Fibrillation Patients Treated With Catheter Ablation

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Oct 1, 2025 to Oct 1, 2027 Show 4 more changesShow less
    • Study completion pushed from Dec 31, 2025 to Dec 31, 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Publications: details revised at 2 of 2 entries
  2. Notable Primary completion date: Oct 1, 2023 to Oct 1, 2025
    • Study completion date: Dec 31, 2023 to Dec 31, 2025
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Recurrence assessed by ECG, Holter reports and outpatient physicians
Timeframe: at 1-year follow-up after ablation
All-cause mortality assessed by telephone follow-up or medical records
Timeframe: at 1-year follow-up after ablation

Secondary (4)

Improvement in life quality assessed by QOLSF36 Questionnaire
Improvement in left atrial function assessed by echocardiography
Embolic events assessed by physicians and further examinations like ultrasound, MRI
Hospitalization for heart failure, atrial fibrillation or atrial flutter

Arms and interventions

atrial fibrillation

Atrial fibrillation patients who underwent radiofrequency ablation in Peking Union Medical College Hospital.

Procedures: radiofrequency ablation

Sites

1 site in 1 country

  • Peking Union Medical College HospitalBeijing, Beijing Municipality, China